CD4 and gastric cancer: Furthermore, co-staining of IL-26 with CD4 and RORγt, a marker for Th17 cells, was observed, with 53.21±16.82% of Th17 cells expressing IL-26 in human gastric cancer samples (Figure 2a5, a6).